Citation: | CHENG Shuping, HE Pei, LIU Yuanfei, WU Lidong. Effectiveness and safety of ketamine and etomidate for rapid sequential intubation: a Meta-analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 82-89. DOI: 10.7619/jcmp.20233344 |
To compare the effectiveness and safety of ketamine and etomidate for rapid sequential intubation.
Randomized controlled trials and cohort studies with ketamine and etomidate for RSI in patients with acute and critical illnesses published by China National Knowledge Infrastructure, Wanfang Data, VIP Network, PubMed, Embase, Cochrane Library and Clinicaltrials.gov from the date of database creation to May 1, 2023 were searched by computer. The literatures were screened according to inclusion and exclusion criteria, and the data of literatures were also extracted for quality assessment. Meta-analysis was performed by RevMan 5.3 software.
A total of 15 literatures with 20 839 patients were included, including 3 RCT studies and 12 cohort studies. Meta-analysis showed that there were no significant differences in the success rate of primary intubation (RR=0.99, 95 %CI, 0.98 to 1.00, P=0.10), incidence of cardiac arrest (RR=1.00, 95 %CI, 0.62 to 1.62, P=0.99), time of mechanical ventilation (MD=0.33, 95 %CI, -0.34 to 1.01, P=0.33), and mortality rate (RR=1.05, 95 %CI, 0.95 to 1.16, P=0.31) between the ketamine group and the etomidate group, but the incidence of adrenal insufficiency (RR=0.54, 95 %CI, 0.41 to 0.70, P < 0.001) and ICU stay (MD=-0.44, 95 %CI, -0.70 to -0.18, P=0.001) in the etomidate group were significantly lower and shorter than those in the ketamine group, while the incidence of hypoxemia was significantly higher in the etomidate group (RR=1.50, 95 %CI, 1.27 to 1.79, P < 0.001).
During the process of RSI with sufficient preoxygenation, ketamine is a safe and effective alternative drug, and compared with etomidate, it has a lower incidence of adrenal insufficiency and shorter ICU stay.
[1] |
MOSIER J M, SAKLES J C, LAW J A, et al. Tracheal intubation in the critically ill. where we came from and where we should go[J]. Am J Respir Crit Care Med, 2020, 201(7): 775-788. doi: 10.1164/rccm.201908-1636CI
|
[2] |
APRIL M D, LONG B, BROWN C A 3rd. Etomidate should be the default agent for rapid sequence intubation in the emergency department[J]. Ann Emerg Med, 2021, 78(6): 720-721. doi: 10.1016/j.annemergmed.2021.05.018
|
[3] |
PEKSA G D, GOTTLIEB M. Ketamine should be the preferred agent for rapid sequence intubation[J]. Ann Emerg Med, 2021, 78(6): 722-723. doi: 10.1016/j.annemergmed.2021.07.118
|
[4] |
ALBERT S G, ARIYAN S, RATHER A. The effect of etomidate on adrenal function in critical illness: a systematic review[J]. Intensive Care Med, 2011, 37(6): 901-910. doi: 10.1007/s00134-011-2160-1
|
[5] |
MERELMAN A H, PERLMUTTER M C, STRAYER R J. Alternatives to rapid sequence intubation: contemporary airway management with ketamine[J]. West J Emerg Med, 2019, 20(3): 466-471. doi: 10.5811/westjem.2019.4.42753
|
[6] |
PATANWALA A E, MCKINNEY C B, ERSTAD B L, et al. Retrospective analysis of etomidate versus ketamine for first-pass intubation success in an academic emergency department[J]. Acad Emerg Med, 2014, 21(1): 87-91. doi: 10.1111/acem.12292
|
[7] |
PRICE B, ARTHUR A O, BRUNKO M, et al. Hemodynamic consequences of ketamine vs etomidate for endotracheal intubation in the air medical setting[J]. Am J Emerg Med, 2013, 31(7): 1124-1132. doi: 10.1016/j.ajem.2013.03.041
|
[8] |
UPCHURCH C P, GRIJALVA C G, RUSS S, et al. Comparison of etomidate and ketamine for induction during rapid sequence intubation ofAdult trauma patients[J]. Ann Emerg Med, 2017, 69(1): 24-33, e2. doi: 10.1016/j.annemergmed.2016.08.009
|
[9] |
WAN C, HANSON A C, SCHULTE P J, et al. Propofol, ketamine, and etomidate as induction agents for intubation and outcomes in critically ill patients: a retrospective cohort study[J]. Crit Care Explor, 2021, 3(5): e0435. doi: 10.1097/CCE.0000000000000435
|
[10] |
MATCHETT G, GASANOVA I, RICCIO C A, et al. Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial[J]. Intensive Care Med, 2022, 48(1): 78-91. doi: 10.1007/s00134-021-06577-x
|
[11] |
APRIL M D, ARANA A, SCHAUER S G, et al. Ketamine versus etomidate and peri-intubation hypotension: a national emergency airway registry study[J]. Acad Emerg Med, 2020, 27(11): 1106-1115. doi: 10.1111/acem.14063
|
[12] |
STANKE L, NAKAJIMA S, ZIMMERMAN L H, et al. Hemodynamic effects of ketamine versus etomidate for prehospital rapid sequence intubation[J]. Air Med J, 2021, 40(5): 312-316. doi: 10.1016/j.amj.2021.05.009
|
[13] |
VAN BERKEL M A, EXLINE M C, CAPE K M, et al. Increased incidence of clinical hypotension with etomidate compared to ketamine for intubation in septic patients: a propensity matched analysis[J]. J Crit Care, 2017, 38: 209-214. doi: 10.1016/j.jcrc.2016.11.009
|
[14] |
FARRELL N M, KILLIUS K, KUE R, et al. A comparison of etomidate, ketamine, and methohexital in emergency department rapid sequence intubation[J]. J Emerg Med, 2020, 59(4): 508-514. doi: 10.1016/j.jemermed.2020.06.054
|
[15] |
MOHR N M, PAPE S G, DAN R D, et al. Etomidate use is associated with less hypotension than ketamine for emergency department sepsis intubations: a NEAR cohort study[J]. Acad Emerg Med, 2020, 27(11): 1140-1149. doi: 10.1111/acem.14070
|
[16] |
DRIVER B ER. Ketamine versus etomidate for rapid sequence intubation[EB/OL]. ClinicalTrials. gov. 2019. Available from: https://clinicaltrials.gov/ct2/show/study/NCT01823328.
|
[17] |
POLLACK M A, FENATI G M, PENNINGTON T W, et al. The use of ketamine for air medical rapid sequence intubation was not associated with a decrease in hypotension or cardiopulmonary arrest[J]. Air Med J, 2020, 39(2): 111-115. doi: 10.1016/j.amj.2019.11.003
|
[18] |
JABRE P, COMBES X, LAPOSTOLLE F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial[J]. Lancet, 2009, 374(9686): 293-300. doi: 10.1016/S0140-6736(09)60949-1
|
[19] |
SIVILOTTI M L, FILBIN M R, MURRAY H E, et al. Does the sedative agent facilitate emergency rapid sequence intubation[J]. Acad Emerg Med, 2003, 10(6): 612-620. doi: 10.1111/j.1553-2712.2003.tb00044.x
|
[20] |
阚景祥, 朱海颖, 赵国芹, 等. 依托咪酯与氯胺酮对ICU脓毒症患者插管后血压的影响[J]. 中国急救医学, 2018, 38(2): 184-188. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJJY201802021.htm
|
[21] |
ENGSTROM K, BROWN C S, MATTSON A E, et al. Pharmacotherapy optimization for rapid sequence intubation in the emergency department[J]. Am J Emerg Med, 2023, 70: 19-29. doi: 10.1016/j.ajem.2023.05.004
|
[22] |
SHARDA S C, BHATIA M S. Etomidate compared to ketamine for induction during rapid sequence intubation: a systematic review and meta-analysis[J]. Indian J Crit Care Med, 2022, 26(1): 108-113. doi: 10.5005/jp-journals-10071-24086
|
[23] |
NATT B S, MALO J, HYPES C D, et al. Strategies to improve first attempt success at intubation in critically ill patients[J]. Br J Anaesth, 2016, 117(Suppl 1): i60-i68.
|
[24] |
GIL-JARDINÉ C, JABRE P, ADNET F, et al. Incidence and factors associated with out-of-hospital peri-intubation cardiac arrest: a secondary analysis of the CURASMUR trial[J]. Intern Emerg Med, 2022, 17(2): 611-617. doi: 10.1007/s11739-021-02903-9
|
[25] |
APRIL M D, ARANA A, REYNOLDS J C, et al. Peri-intubation cardiac arrest in the Emergency Department: a National Emergency Airway Registry (NEAR) study[J]. Resuscitation, 2021, 162: 403-411. doi: 10.1016/j.resuscitation.2021.02.039
|
[26] |
SMISCHNEY N J, KHANNA A K, BRAUER E, et al. Risk factors for and outcomes associated with peri-intubation hypoxemia: a multicenter prospective cohort study[J]. J Intensive Care Med, 2021, 36(12): 1466-1474. doi: 10.1177/0885066620962445
|
[27] |
RUSSOTTO V, MYATRA S N, LAFFEY J G, et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries[J]. JAMA, 2021, 325(12): 1164-1172. doi: 10.1001/jama.2021.1727
|
[28] |
VALK B I, STRUYS M M R F. Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics[J]. Clin Pharmacokinet, 2021, 60(10): 1253-1269. doi: 10.1007/s40262-021-01038-6
|
[29] |
BRUDER E A, BALL I M, RIDI S, et al. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients[J]. Cochrane Database Syst Rev, 2015, 1(1): CD010225.
|
[30] |
KUZA C M, TO J, CHANG A, et al. A retrospective data analysis on the induction medications used in trauma rapid sequence intubations and their effects on outcomes[J]. Eur J Trauma Emerg Surg, 2022, 48(3): 2275-2286. doi: 10.1007/s00068-021-01759-0
|
1. |
胡武彩,周桂生. 尿八联检验联合定量尿培养在尿路感染中的诊断效能. 系统医学. 2024(03): 61-64 .
![]() | |
2. |
邱玉琳. 全血C反应蛋白和白细胞及尿常规联合检测对尿路感染的诊断价值. 医疗装备. 2024(15): 74-76 .
![]() | |
3. |
武颖,龚正,刘航,王美燕,燕慧. 2019—2020年北京市丰台中西医结合医院的尿细菌培养情况及药敏分析. 中国当代医药. 2023(11): 157-160 .
![]() | |
4. |
崔玉荣. 干化学法与尿沉渣法在尿常规检验中的应用价值. 实用检验医师杂志. 2023(03): 258-261 .
![]() | |
5. |
杨海东,周文博,罗景,段南均. 上尿路结石感染的病原学特征及即刻引流效果分析. 实用临床医药杂志. 2022(05): 71-74 .
![]() | |
6. |
杨超,刘健,申忠华,崔海军,张慧民,郝俊秀,裴琼. 唐山市工人医院2018年-2021年泌尿系结石感染患者的细菌谱变迁及药敏特点分析. 中国现代医学杂志. 2022(15): 79-84 .
![]() | |
7. |
周旭瑜. Mejer-7001尿沉渣分析仪与细菌培养检查诊断尿路感染的一致性分析. 基层医学论坛. 2021(14): 2026-2027 .
![]() | |
8. |
宋培培,张琴,许健,王秦,刘成桂. 某三甲医院儿童和成年女性尿培养病原菌分布和耐药性分析. 现代生物医学进展. 2021(12): 2344-2349 .
![]() | |
9. |
郑萍萍,张丽华. 改良尿标本留取方式对中段尿培养结果的影响. 名医. 2021(22): 80-81 .
![]() |